Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions

International Journal of Medical Microbiology

Volumn 303, Issue 6-7, 2013, Pages 287-292

  Cox, Georgina ^a   Wright, Gerard D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Adjuvant; Antibiotic resistance; Efflux; Gram negative pathogens; Intrinsic antibiotic resistance; Outer membrane; Permeability; Potentiate; Resistome

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CIPROFLOXACIN; DAPTOMYCIN; FATTY ACID; GLYCEROPHOSPHATE; GLYCEROPHOSPHOLIPID; GLYCYLCYCLINE DERIVATIVE; IMIDAZOLE; LOPERAMIDE; MACROLIDE; METRONIDAZOLE; MINOCYCLINE; NISIN; POLYMYXIN; POLYMYXIN B NONAPEPTIDE; POLYSACCHARIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; VANCOMYCIN;

ACINETOBACTER BAYLYI; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GROWTH; BACTERIAL MEMBRANE; CELL FUNCTION; CELL MEMBRANE; ESCHERICHIA COLI; GENE LOCUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; MULTIDRUG RESISTANCE; NONHUMAN; OUTER MEMBRANE; PATHOGENESIS; PERMEABILITY; PHENOTYPE; PSEUDOMONAS AERUGINOSA; SHORT SURVEY;

ADJUVANT; ANTIBIOTIC RESISTANCE; EFFLUX; GRAM-NEGATIVE PATHOGENS; INTRINSIC ANTIBIOTIC RESISTANCE; OUTER MEMBRANE; PERMEABILITY; POTENTIATE; RESISTOME;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; METABOLIC NETWORKS AND PATHWAYS;

EID: 84880714264     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2013.02.009     Document Type: Short Survey

References (83)

1. Alvarez-Ortega C., Wiegand I., Olivares J., Hancock R.E., Martinez J.L. The intrinsic resistome of Pseudomonas aeruginosa to beta-lactams. Virulence 2011, 2:144-146.
2. Bailey A.M., Paulsen I.T., Piddock L.J. RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine. Antimicrob. Agents Chemother. 2008, 52:3604-3611.
3. Ball P.R., Chopra I., Eccles S.J. Accumulation of tetracyclines by Escherichia coli K-12. Biochem. Biophys. Res. Commun. 1977, 77:1500-1507.
4. Ball P.R., Shales S.W., Chopra I. Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem. Biophys. Res. Commun. 1980, 93:74-81.
5. Bellido F., Martin N.L., Siehnel R.J., Hancock R.E. Reevaluation, using intact cells, of the exclusion limit and role of porin OprF in Pseudomonas aeruginosa outer membrane permeability. J. Bacteriol. 1992, 174:5196-5203.
6. Benz R., Bauer K. Permeation of hydrophilic molecules through the outer-membrane of Gram-negative bacteria - review on bacterial porins. Eur. J. Biochem. 1988, 176:1-19.
7. Bhullar K., Waglechner N., Pawlowski A., Koteva K., Banks E.D., Johnston M.D., Barton H.A., Wright G.D. Antibiotic resistance is prevalent in an isolated cave microbiome. PloS ONE 2012, 7:e34953.
8. Blair J.M., Piddock L.J. Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update. Curr. Opin. Microbiol. 2009, 12:512-519.
9. Blake K.L., O'Neill A.J. Transposon library screening for identification of genetic loci participating in intrinsic susceptibility and acquired resistance to antistaphylococcal agents. J. Antimicrob. Chemother. 2013, 68:12-16.
10. Breidenstein E.B., Khaira B.K., Wiegand I., Overhage J., Hancock R.E. Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob. Agents Chemother. 2008, 52:4486-4491.
11. Chan Y.Y., Ong Y.M., Chua K.L. Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei. Antimicrob. Agents Chemother. 2007, 51:623-630.
12. Chollet R., Chevalier J., Bryskier A., Pages J.M. The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob. Agents Chemother. 2004, 48:3621-3624.
13. Chopra I., Schofield C., Everett M., O'Neill A., Miller K., Wilcox M., Frere J.M., Dawson M., Czaplewski L., Urleb U., Courvalin P. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect. Dis. 2008, 8:133-139.
14. Cowan S.W., Schirmer T., Rummel G., Steiert M., Ghosh R., Pauptit R.A., Jansonius J.N., Rosenbusch J.P. Crystal structures explain functional properties of two E. coli porins. Nature 1992, 358:727-733.
15. Cundliffe E., Bate N., Butler A., Fish S., Gandecha A., Merson-Davies L. The tylosin-biosynthetic genes of Streptomyces fradiae. Antonie Van Leeuwenhoek 2001, 79:229-234.
16. D'Costa V.M., King C.E., Kalan L., Morar M., Sung W.W., Schwarz C., Froese D., Zazula G., Calmels F., Debruyne R., Golding G.B., Poinar H.N., Wright G.D. Antibiotic resistance is ancient. Nature 2011, 477:457-461.
17. D'Costa V.M., McGrann K.M., Hughes D.W., Wright G.D. Sampling the antibiotic resistome. Science 2006, 311:374-377.
18. Dantas G., Sommer M.O., Oluwasegun R.D., Church G.M. Bacteria subsisting on antibiotics. Science 2008, 320:100-103.
19. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994, 264:375-382.
20. Davies J.E. Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba Found. Symp. 1997, 207:15-27. (discussion 27-35).
21. Dean C.R., Visalli M.A., Projan S.J., Sum P.E., Bradford P.A. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob. Agents Chemother. 2003, 47:972-978.
22. Decad G.M., Nikaido H. Outer membrane of gram-negative bacteria, XII. Molecular-sieving function of cell wall. J. Bacteriol. 1976, 128:325-336.
23. Ejim L., Farha M.A., Falconer S.B., Wildenhain J., Coombes B.K., Tyers M., Brown E.D., Wright G.D. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat. Chem. Biol. 2011, 7:348-350.
24. Fajardo A., Martinez-Martin N., Mercadillo M., Galan J.C., Ghysels B., Matthijs S., Cornelis P., Wiehlmann L., Tummler B., Baquero F., Martinez J.L. The neglected intrinsic resistome of bacterial pathogens. PloS ONE 2008, 3:e1619.
25. Forsberg K.J., Reyes A., Wang B., Selleck E.M., Sommer M.O., Dantas G. The shared antibiotic resistome of soil bacteria and human pathogens. Science 2012, 337:1107-1111.
26. Girgis H.S., Hottes A.K., Tavazoie S. Genetic architecture of intrinsic antibiotic susceptibility. PloS ONE 2009, 4:e5629.
27. Gomez M.J., Neyfakh A.A. Genes involved in intrinsic antibiotic resistance of Acinetobacter baylyi. Antimicrob. Agents Chemother. 2006, 50:3562-3567.
28. Guardabassi L., Dalsgaard A. Occurrence, structure, and mobility of Tn1546-like elements in environmental isolates of vancomycin-resistant enterococci. Appl. Environ. Microbiol. 2004, 70:984-990.
29. Hancock R.E., Brinkman F.S. Function of pseudomonas porins in uptake and efflux. Annu. Rev. Microbiol. 2002, 56:17-38.
30. Hogan D., Kolter R. Why are bacteria refractory to antimicrobials?. Curr. Opin. Microbiol. 2002, 5:472-477.
31. Hong H.J., Paget M.S., Buttner M.J. A signal transduction system in Streptomyces coelicolor that activates the expression of a putative cell wall glycan operon in response to vancomycin and other cell wall-specific antibiotics. Mol. Microbiol. 2002, 44:1199-1211.
32. Hubbard B.K., Walsh C.T. Vancomycin assembly: nature's way. Angew. Chem. Int. Ed. Engl. 2003, 42:730-765.
33. Levy S.B., McMurry L. Plasmid-determined tetracycline resistance involves new transport systems for tetracycline. Nature 1978, 276:90-92.
34. Li X.Z., Ma D., Livermore D.M., Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance. Antimicrob. Agents Chemother. 1994, 38:1742-1752.
35. Liu A., Tran L., Becket E., Lee K., Chinn L., Park E., Tran K., Miller J.H. Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code. Antimicrob. Agents Chemother. 2010, 54:1393-1403.
36. Livermore D.M. Linezolid in vitro: mechanism and antibacterial spectrum. J. Antimicrob. Chemother. 2003, 51(Suppl. 2):ii9-ii16.
37. Lomovskaya O., Warren M.S., Lee A., Galazzo J., Fronko R., Lee M., Blais J., Cho D., Chamberland S., Renau T., Leger R., Hecker S., Watkins W., Hoshino K., Ishida H., Lee V.J. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 2001, 45:105-116.
38. Madigan M.T., Brock T.D. Brock Biology of Microorganisms 2009, vol. 12. Benjamin Cummings Publishers, San Francisco.
39. Marquez B. Bacterial efflux systems and efflux pumps inhibitors. Biochimie 2005, 87:1137-1147.
40. Marshall C.G., Lessard I.A., Park I., Wright G.D. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob. Agents Chemother. 1998, 42:2215-2220.
41. Martinez J.L., Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 2000, 44:1771-1777.
42. Martinez J.L., Baquero F., Andersson D.I. Predicting antibiotic resistance. Nat. Rev. Microbiol. 2007, 5:958-965.
43. McMurry L., Petrucci R.E., Levy S.B. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 1980, 77:3974-3977.
44. Molina J., Cordero E., Pachon J. New information about the polymyxin/colistin class of antibiotics. Expert Opin. Pharmacother. 2009, 10:2811-2828.
45. Murakami S., Nakashima R., Yamashita E., Yamaguchi A. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 2002, 419:587-593.
46. Nakae T., Nakajima A., Ono T., Saito K., Yoneyama H. Resistance to beta-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and beta-lactamase. Antimicrob. Agents Chemother. 1999, 43:1301-1303.
47. Nelson M.L., Levy S.B. Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein. Antimicrob. Agents Chemother. 1999, 43:1719-1724.
48. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 1994, 264:382-388.
49. Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 2003, 67:593-656.
50. Nikaido H., Nikaido K., Harayama S. Identification and characterization of porins in Pseudomonas aeruginosa. J. Biol. Chem. 1991, 266:770-779.
51. Nikaido H., Rosenberg E.Y., Foulds J. Porin channels in Escherichia coli: studies with beta-lactams in intact cells. J. Bacteriol. 1983, 153:232-240.
52. Obst S., Kastowsky M., Bradaczek H. Molecular dynamics simulations of six different fully hydrated monomeric conformers of Escherichia coli re-lipopolysaccharide in the presence and absence of Ca2+. Biophys. J. 1997, 72:1031-1046.
53. Ochs M.M., McCusker M.P., Bains M., Hancock R.E. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob. Agents Chemother. 1999, 43:1085-1090.
54. Olesky M., Zhao S., Rosenberg R.L., Nicholas R.A. Porin-mediated antibiotic resistance in Neisseria gonorrhoeae: ion, solute, and antibiotic permeation through PIB proteins with penB mutations. J. Bacteriol. 2006, 188:2300-2308.
55. Pages J.M., Amaral L. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim. Biophys. Acta 2009, 1794:826-833.
56. Pages J.M., Masi M., Barbe J. Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol. Med. 2005, 11:382-389.
57. Parr T.R., Moore R.A., Moore L.V., Hancock R.E. Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob. Agents Chemother. 1987, 31:121-123.
58. Paulsen I.T., Brown M.H., Skurray R.A. Proton-dependent multidrug efflux systems. Microbiol. Rev. 1996, 60:575-608.
59. Peric M., Bozdogan B., Jacobs M.R., Appelbaum P.C. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob. Agents Chemother. 2003, 47:1017-1022.
60. Piddock L.J. Multidrug-resistance efflux pumps - not just for resistance. Nat. Rev. Microbiol. 2006, 4:629-636.
61. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 2004, 10:12-26.
62. Poole K., Krebes K., McNally C., Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 1993, 175:7363-7372.
63. Randall C.P., Mariner K.R., Chopra I., O'Neill A.J. The target of daptomycin is absent from Escherichia coli and other Gram-negative pathogens. Antimicrob. Agents Chemother. 2013, 57:637-639.
64. Rice L.B. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin. Infect. Dis. 2006, 43(Suppl. 2):S100-S105.
65. Ruiz N., Montero T., Hernandez-Borrell J., Vinas M. The role of Serratia marcescens porins in antibiotic resistance. Microb. Drug Resist. 2003, 9:257-264.
66. Schaffer C., Messner P. The structure of secondary cell wall polymers: how Gram-positive bacteria stick their cell walls together. Microbiology 2005, 151:643-651.
67. Scherrer R., Gerhardt P. Molecular sieving by the Bacillus megaterium cell wall and protoplast. J. Bacteriol. 1971, 107:718-735.
68. Schurek K.N., Marr A.K., Taylor P.K., Wiegand I., Semenec L., Khaira B.K., Hancock R.E. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2008, 52:4213-4219.
69. Seeger M.A., Schiefner A., Eicher T., Verrey F., Diederichs K., Pos K.M. Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science 2006, 313:1295-1298.
70. Sennhauser G., Bukowska M.A., Briand C., Grutter M.G. Crystal structure of the multidrug exporter MexB from Pseudomonas aeruginosa. J. Mol. Biol. 2009, 389:134-145.
71. Sommer M.O., Dantas G., Church G.M. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009, 325:1128-1131.
72. Tamae C., Liu A., Kim K., Sitz D., Hong J., Becket E., Bui A., Solaimani P., Tran K.P., Yang H., Miller J.H. Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli. J. Bacteriol. 2008, 190:5981-5988.
73. Taylor P.L., Rossi L., De Pascale G., Wright G.D. A forward chemical screen identifies antibiotic adjuvants in Escherichia coli. ACS Chem. Biol. 2012, 7:1547-1555.
74. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 1992, 56:395-411.
75. Vaara M. Agents that increase the permeability of the outer-membrane. Microbiol. Rev. 1992, 56:395-411.
76. Van Bambeke F., Balzi E., Tulkens P.M. Antibiotic efflux pumps. Biochem. Pharmacol. 2000, 60:457-470.
77. Vance G.E., Vance J. Biochemistry of Lipids, Lipoproteins and Membranes 1996, Elsevier, Paris.
78. Viveiros M., Martins A., Paixao L., Rodrigues L., Martins M., Couto I., Fahnrich E., Kern W.V., Amaral L. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int. J. Antimicrob. Agents 2008, 31:458-462.
79. Webber M.A., Piddock L.J. The importance of efflux pumps in bacterial antibiotic resistance. J. Antimicrob. Chemother. 2003, 51:9-11.
80. Wiuff C., Zappala R.M., Regoes R.R., Garner K.N., Baquero F., Levin B.R. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob. Agents Chemother. 2005, 49:1483-1494.
81. Wright G.D. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 2007, 5:175-186.
82. Yuan Z., Tam V.H. Polymyxin B. a new strategy for multidrug-resistant Gram-negative organisms. Expert Opin. Investig. Drugs 2008, 17:661-668.
83. Zavascki A.P., Goldani L.Z., Li J., Nation R.L. Polymyxin B, for the treatment of multidrug-resistant pathogens: a critical review. J. Antimicrob. Chemother. 2007, 60:1206-1215.